- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Myeloid, Accelerated Phase in United Kingdom
Total 2577 results
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalWithdrawn
-
University of PittsburghTerminatedAcute Myeloid LeukemiaUnited States
-
University of PittsburghTerminatedAcute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalCompleted
-
Dutch Childhood Oncology GroupSt. Jude Children's Research Hospital; International BFM Study GroupCompletedAcute Myeloid LeukemiaUnited States
-
Hetty CarrawayActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Eisai Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedHematopoietic and Lymphoid Cell Neoplasm | Diffuse Large B-Cell Lymphoma | Refractory Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Plasma Cell Myeloma | Refractory Chronic Lymphocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Chronic Phase Chronic Myelogenous... and other conditionsUnited States, Germany, Italy
-
Boehringer IngelheimTerminatedLeukemia, Myeloid, AcuteUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingAcute Myeloid Leukemia, in RelapseUnited States
-
Georgetown UniversityNational Heart, Lung, and Blood Institute (NHLBI); Jazz PharmaceuticalsRecruitingAcute Myeloid Leukemia (AML) in RemissionUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Alkylating Agent-Related Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Sumitomo Pharma America, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalSyndax PharmaceuticalsRecruitingRefractory Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Relapsed Acute Myeloid LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)WithdrawnAcute Myeloid LeukemiaUnited States
-
University of IowaTerminatedAcute Myeloid LeukemiaUnited States
-
Washington University School of MedicineCelgene CorporationCompleted
-
Washington University School of MedicineCompleted
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalDuke UniversityActive, not recruitingAcute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalGateway for Cancer ResearchCompleted
-
Hoffmann-La RocheTerminated
-
Polaris GroupCompleted
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Roswell Park Cancer InstituteCompletedPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedSecondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With Gene Mutations | FLT3 Tyrosine Kinase Domain Point MutationUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Leukemia Cutis | Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLUnited States
-
John QuigleyPfizer; AbbVieActive, not recruiting
-
University Health Network, TorontoMemorial Sloan Kettering Cancer Center; University of California, Los Angeles; University of KansasCompletedAcute Myeloid LeukemiaUnited States, Canada
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid LeukemiaUnited States
-
Coronado Biosciences, Inc.Unknown
-
AstraZenecaCompletedAcute Myeloid LeukemiaUnited States, France
-
Massachusetts General HospitalBlue Note TherapeuticsTerminated
-
Massachusetts General HospitalRecruitingAcute Myeloid LeukemiaUnited States
-
Oscotec Inc.PPDCompletedAcute Myeloid LeukemiaUnited States
-
Columbia UniversityThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Myeloid LeukemiaUnited States
-
Cyclacel Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, France, Switzerland, Germany, Italy, Austria, Sweden, Hungary, Belgium, Poland, United Kingdom
-
Medical College of WisconsinCompletedRelapsed Adult AMLUnited States
-
M.D. Anderson Cancer CenterBayerCompletedAcute Myeloid Leukemia | AML | Myelodysplastic DisordersUnited States
-
M.D. Anderson Cancer CenterCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
AbbVieTerminatedAcute Myeloid Leukemia (AML)United States